|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Affymetrix Pushes Into Diagnostics, Acquiring eBioscience for $330M
|
Luke Timmerman |
11/30/11 |
San Francisco
|
|
NanoString Grabs $20M From GE, Former Genzyme CEO to Pursue Molecular Diagnostics
|
Luke Timmerman |
11/07/11 |
Seattle
|
|
PacBio Posts Flat Revenues in Q3, Names Mike Hunkapiller New Executive Chairman
|
Luke Timmerman |
10/27/11 |
San Francisco
|
|
Illumina To Cut 200 Jobs, 8 Percent of Workforce, After Third Quarter Sales Fall Short
|
Luke Timmerman |
10/25/11 |
San Diego
|
|
Amgen Mulls R&D Cuts, Thong Le Named WBBA Chairman, NanoString’s Version 2.0, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/13/11 |
Seattle
|
|
NanoString Rolls Out Souped-Up DNA Analysis Instrument at Genetics Confab
|
Luke Timmerman |
10/12/11 |
Seattle
|
|
Illumina Stock Dives on Weak Quarterly Sales Report
|
Luke Timmerman |
10/07/11 |
San Diego
|
|
Women in Bio’s Seattle Chapter Kick-Off: The Photo Gallery
|
Luke Timmerman |
09/16/11 |
Seattle
|
|
Ion Torrent’s Fast and Cheap DNA Sequencer Catches On, Even as Biologists Tighten Belts
|
Luke Timmerman |
09/15/11 |
National
|
|
PacBio, Following Fast Behind Rivals, Seeks Answers for Germany’s E.Coli Outbreak
|
Luke Timmerman |
07/27/11 |
San Francisco
|
|
Illumina Sales Climb 36%, Profits Flat
|
Luke Timmerman |
07/26/11 |
San Diego
|
|
The Missing Ingredient in Today’s Biotech: Guts
|
Luke Timmerman |
07/11/11 |
National
|
|
Fluidigm, Life Settle Legal Dispute
|
Luke Timmerman |
07/06/11 |
San Francisco
|
|
NanoString Adds $2.5M Financing
|
Luke Timmerman |
06/30/11 |
Seattle
|
|
PacBio Chief Scientist Heads to NYC to Run New $100M Genomics Center at Mt. Sinai
|
Luke Timmerman |
05/16/11 |
San Francisco
|
|
Cell Biosciences Boosts F Round, Buys Brightwell
|
Wade Roush |
05/13/11 |
San Francisco
|
|
PacBio Goes Commercial, Tweet by Tweet from BayBio, VCs Turn Up the Heat on FDA, & More Bay Area Life Sciences News
|
Luke Timmerman |
04/29/11 |
San Francisco
|
|
GE Healthcare Buys Applied Precision
|
Luke Timmerman |
04/28/11 |
Seattle
|
|
PacBio, After 7 Years and $580M, Starts Shipping New Generation DNA Sequencer
|
Luke Timmerman |
04/27/11 |
San Francisco
|
|
NanoString Names VPs
|
Luke Timmerman |
02/15/11 |
Seattle
|
|
Fluidigm Completes IPO on 2nd Try, Geron CEO Exits, Amgen Pushes ‘Son of Dmab,’ & More Bay Area Life Sciences News
|
Luke Timmerman |
02/11/11 |
San Francisco
|
|
Fluidigm Raises $75M in Second Chance at IPO
|
Luke Timmerman |
02/10/11 |
San Francisco
|
|
NanoString, Snapping Up Genomic Health Veteran, Seeks to Prove Economic Value of Cancer Diagnostic
|
Luke Timmerman |
02/03/11 |
Seattle
|
|
California Biotech, Despite Lots of Ugliness, Poised to Add Jobs, CEO Survey Says
|
Luke Timmerman |
02/01/11 |
San Francisco
|
|
From Bordeaux to San Diego: Portable Genomics on the Move
|
Bruce V. Bigelow |
01/14/11 |
San Diego
|
|
Two Thermo Fisher Units on Block, Bloomberg Reports
|
Ryan McBride |
01/12/11 |
Boston
|
|
615 Human Genomes? Another Cheap, Fast Sequencing Machine? Complete Genomics, Illumina Steal Show at Healthcare Meeting
|
Luke Timmerman |
01/12/11 |
National
|
|
On-Q-ity Strikes Deal With LabCorp To Help Researchers Spot Rare Tumor Cells
|
Luke Timmerman |
01/10/11 |
Boston
|
|
Life Technologies Debuts Ion Torrent Machine, Next Big Bet on Fast, Cheap Sequencing
|
Luke Timmerman |
12/14/10 |
San Diego
|
|
Fluidigm, Maker of Genomic Tools, Takes Second Crack at IPO, Hoping for Less Drama
|
Luke Timmerman |
12/14/10 |
San Francisco
|
|
Page 1 of
3 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.